HbO2 Therapeutics Revenue

Biotechnology Research • Franconia, Pennsylvania, United States • 1-10 Employees

HbO2 Therapeutics revenue & valuation

Annual revenue	$35,470
Revenue per employee	$6,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$113,504
Total funding	$150,000

Key Contact at HbO2 Therapeutics

Fantao Meng

Director Of Research Development

Company overview

Headquarters	674 Souder Rd, Souderton, Pennsylvania 18964, US
Phone number	+12673820064
Website	hbo2therapeutics.com
NAICS	541714
SIC	873
Founded	2014
Employees	1-10
Socials

About HbO2 Therapeutics

Hemoglobin Oxygen Therapeutics LLC (HbO2 Therapeutics) is a leading developer and manufacturer of oxygen carrying solutions, a class of drug products that when administered intravenously can increase the amount of oxygen transported throughout the body. We have developed two products. Hemopure® [hemoglobin glutamer – 250 (bovine)], for use in humans, and Oxyglobin® [hemoglobin glutamer – 200 (bovine)]) for veterinary use. Oxyglobin is the only oxygen carrying solution approved by the FDA and the European Medicines Agency (EMA) to treat all cause canine anemia. Hemopure is approved in South Africa to treat adult surgical patients who are anemic, and in the Russian Federation for acute anemia, irrespective of etiology. In the US Hemopure is only available under investigational status through the FDA expanded access program to qualifying patients with severe, life threatening anemia for whom blood transfusion is not an option, and who have exhausted all other treatment options. Blood transfusion may not be an option due to religious beliefs, or because no compatible blood is available for a patient needing transfusion.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Manager

Vice President

Employees by Department

HbO2 Therapeutics has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore HbO2 Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2015-05-13	3	$150,000

Funding Insights

$150,000

Total funding amount

$150,000

Most recent funding amount

Number of funding rounds

HbO2 Therapeutics Tech Stack

Discover the technologies and tools that power HbO2 Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Lodash

JavaScript libraries

Sentry

Issue trackers

Sirvoy

Appointment scheduling

Wix

Blogs

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

React

JavaScript frameworks

Google Cloud

IaaS

Google Cloud CDN

CDN

RSS

Miscellaneous

Frequently asked questions

HbO2 Therapeutics is located in Franconia, Pennsylvania, US.

You can reach HbO2 Therapeutics at +12673820064.

HbO2 Therapeutics generates an estimated annual revenue of $35,470. This revenue figure reflects the company's market position and business performance in its industry.

HbO2 Therapeutics has an estimated valuation of $113,504. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

HbO2 Therapeutics was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

HbO2 Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

HbO2 Therapeutics has raised a total of $150,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at HbO2 Therapeutics

Fantao Meng

Director Of Research Development

4.8

40,000 users